Prof. Andres Floto
Professor of Respiratory Biology, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
Research Director and Honorary Consultant at the Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.
Prof. Andres Floto is interested in understanding how antigen processing is carried out by macrophages and dendritic cells and how it may be subverted by pathogenic bacteria. He is studying how M. tuberculosis and non-tuberculous mycobacteria interact with macrophages and dendritic cells, particularly defining novel host factors controlling bacterial detection, intracellular killing and antigen presentation; he also works with the Wellcome Trust Genome Campus (Dr Julian Parkhill) on new genetic determinants controlling the pathogenesis through the combination of whole genome sequencing, in vitro functional phenotyping and clinical disease characteristics. He is involved in the Cambridge Chennai collaboration funded by MRC-Newton Fund and DBT. Dr. Floto brings first hand clinical experience of treating bacterial infections, along with his knowledge in cell biology, Mtb strain variation, polymorphisms and drug resistance to the workshop.
Sir Simon Campbell
Lady Margaret Beaufort Fellow at Christ’s College Cambridge, University of Cambridge, UK.
Sir Simon Campbell is an innovative medicinal chemist who has made notable contributions to the pharmaceutical industry. Beginning his career in academia in North and South America, Simon next moved to Pfizer at Sandwich in the United Kingdom where over 26 years he was directly involved in the discovery of three of the world's best-selling prescription drugs.
Two of the drugs that he invented, doxazosin and amplodipine, are treatments for high blood pressure — with both considered ‘best in class’ with respect to therapeutic profile. He also played a leading role in the discovery of sildenafil, more commonly known as Viagra. All three continue to be highly successful commercial drugs.
Since his retirement from Pfizer in 1998, he has been President of the Royal Society of Chemistry (from 2004 to 2006) and acts as a scientific consultant to industry, charities and governments around the world. He received honorary Doctor of Science degrees from Birmingham, Kent and St Andrews. Simon received a CBE for services to science in 2006 and a knighthood for services to chemistry in the 2015 New Year Honours list.
Dr. Nirmal K. Ganguly
Professor of Eminence at the Department of Biotechnology, Translational Health Science and Technology Institute (THSTI) and President of Jawaharlal Institute of Post Graduate Medical Education and Research.
Dr. Ganguly is a former Director General of the Indian Council of Medical Research. He has chaired and participated in several meetings on AMR, with insights in both policy and scientific research. He is also the chairman of the Global Antibiotic Resistance Partnership-India National Working Group.
Dr. Tanjore S. Balganesh
Chief Scientific Officer at Gangagen Biotechnologies Pvt. Ltd.
Dr. Balganesh has three decades of experience in the area of antibacterial drug discovery. As the Head of Research at AstraZeneca (AZ), Bangalore India, he led the unit to deliver AZ's first anti-tuberculosis molecule for clinical development. He served as the Project Head of the OSDD unit which focused on drug discovery for neglected tropical diseases. He was also responsible for initiating the anti-malarial drug discovery programme at AZ, India, which was a highly successful project that worked closely with Medicines for Malaria Venture. He has more than 30 publications and 10 patents to his credit.